Aspen Aerogels (NYSE:ASPN) Stock Price Up 13.6% - Still a Buy?

Key Points

• Aspen Aerogels' stock price surged 13.6% on Monday, closing at $8.82, despite a significant drop in trading volume by 48% compared to its average daily trading.
• Analysts have mixed views on the stock, with **a consensus rating of "Moderate Buy"** and an average price target of $19.50; however, recent ratings include one Strong Buy, six Buy, and two Sell ratings.
• The company reported **earnings per share (EPS) of ($0.04)** for the last quarter, outperforming the consensus estimate, but faced a year-over-year revenue decline of **33.8%**.

Aspen Aerogels, Inc. (NYSE:ASPN - Get Free Report)'s share price rose 13.6% on Monday . The stock traded as high as $8.89 and last traded at $8.82. Approximately 1,010,376 shares traded hands during mid-day trading, a decline of 48% from the average daily volume of 1,948,215 shares. The stock had previously closed at $7.76.

Analyst Ratings Changes

ASPN has been the subject of several research reports. Canaccord Genuity Group dropped their target price on shares of Aspen Aerogels from $11.00 to $10.00 and set a "buy" rating for the company in a report on Friday, August 8th. Weiss Ratings restated a "sell (d)" rating on shares of Aspen Aerogels in a research note on Saturday, September 27th. Finally, Barclays downgraded shares of Aspen Aerogels from an "equal weight" rating to an "underweight" rating and boosted their price target for the stock from $7.00 to $16.00 in a research note on Monday, August 11th. One research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating, two have issued a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average price target of $19.50.

Aspen Aerogels Trading Up 12.2%

The company's 50 day simple moving average is $7.10 and its 200 day simple moving average is $6.43. The firm has a market cap of $717.36 million, a price-to-earnings ratio of -2.29 and a beta of 2.80. The company has a debt-to-equity ratio of 0.34, a current ratio of 3.98 and a quick ratio of 3.31.

Aspen Aerogels (NYSE:ASPN - Get Free Report) last released its quarterly earnings data on Thursday, August 7th. The construction company reported ($0.04) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.12) by $0.08. The business had revenue of $78.02 million during the quarter, compared to analysts' expectations of $72.53 million. Aspen Aerogels had a negative net margin of 78.53% and a positive return on equity of 2.92%. The company's revenue for the quarter was down 33.8% on a year-over-year basis. During the same period in the previous year, the company earned $0.21 EPS. Aspen Aerogels has set its FY 2025 guidance at -3.860--3.730 EPS. As a group, research analysts expect that Aspen Aerogels, Inc. will post 0.17 earnings per share for the current fiscal year.

Insider Activity

In related news, CAO Santhosh P. Daniel sold 4,410 shares of the business's stock in a transaction on Tuesday, August 12th. The shares were sold at an average price of $7.31, for a total value of $32,237.10. Following the completion of the sale, the chief accounting officer directly owned 19,879 shares of the company's stock, valued at $145,315.49. The trade was a 18.16% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Company insiders own 3.40% of the company's stock.

Institutional Investors Weigh In On Aspen Aerogels

Institutional investors and hedge funds have recently bought and sold shares of the stock. Vanguard Group Inc. raised its holdings in shares of Aspen Aerogels by 0.3% in the first quarter. Vanguard Group Inc. now owns 4,373,159 shares of the construction company's stock valued at $27,944,000 after buying an additional 12,913 shares during the last quarter. Needham Investment Management LLC lifted its position in shares of Aspen Aerogels by 14.5% during the 1st quarter. Needham Investment Management LLC now owns 2,737,200 shares of the construction company's stock valued at $17,491,000 after acquiring an additional 347,500 shares during the period. AWM Investment Company Inc. grew its holdings in Aspen Aerogels by 102.6% in the first quarter. AWM Investment Company Inc. now owns 2,449,221 shares of the construction company's stock valued at $15,651,000 after purchasing an additional 1,240,535 shares during the last quarter. Gagnon Securities LLC acquired a new stake in shares of Aspen Aerogels in the second quarter valued at approximately $11,243,000. Finally, Federated Hermes Inc. acquired a new stake in shares of Aspen Aerogels in the second quarter valued at approximately $10,459,000. 97.64% of the stock is owned by hedge funds and other institutional investors.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.